AVITA MEDICAL, INC. (RCEL)

Every figure this model derived for RCEL, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-06-30.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 1,005,000 PaymentsToAcquirePropertyPlantAndEquipment 2025-12-31
cash 11,135,000 CashAndCashEquivalentsAtCarryingValue 2026-06-30
current assets 28,394,000 AssetsCurrent 2026-06-30
current liabilities 68,714,000 LiabilitiesCurrent 2026-06-30
equity -27,838,000 StockholdersEquity 2026-06-30
interest expense 5,405,000 InterestExpense 2026-06-30
ocf -24,225,000 NetCashProvidedByUsedInOperatingActivities 2026-06-30
revenue 74,881,000 RevenueFromContractWithCustomerIncludingAssessedTax 2026-06-30
sbc 7,239,000 ShareBasedCompensation 2026-06-30

The ratios

The figures themselves rather than their scores — what somebody looking up RCEL on one particular measure came for.

RatioValue
cash operating margin-34.02
current ratio0.41
current ratio reported0.41
dilution pct7.65
fcf margin-33.69
growth cv0.82
interest cover-6.52
operating margin-47.03
owner earnings margin-43.36
revenue growth0.98
revenue growth per share-6.2
roic-362.0
rpo growth-10.0
rule of 40-46.06
sbc pct revenue9.67

What to be careful about

What this model itself distrusts about RCEL's figures. Written by the derivation as it ran, not added afterwards.